Experiences from inborn errors of immunity registry of India: A preliminary report
The Indian Journal of Medical Research · 13.03.2026 · 163 · 207-214
DOI: 10.25259/ijmr_1850_2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Indian Journal of Medical Research, online erschienen am 13.03.2026. Verfasst von Reetika Malik Yadav und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Immunology and Leucocyte Biology, ICMR- National Institute of Immunohaematology, Mumbai, Maharashtra, India. Hauptthemen laut MEDLINE: Registries, Rare Diseases, Immunologic Deficiency Syndromes. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background and objectives Global estimates identify about 7,000 rare diseases affecting 6–8% of the population, with 80% being genetic. India lacks comprehensive data on their prevalence, distribution, and natural history. Inborn errors of immunity (IEI) registry was developed by Indian Council of Medical Research (ICMR) as part of a comprehensive multi-centric ‘National Registry for Rare and Other Inherited Disorders’, from centres which expressed interest in contributing to this national database in 2019. This study aims to establish an Indian rare-disease registry to assess disease burden, collect clinical and demographic data, understand natural history, support research on underlying mechanisms, create cohorts for evaluating therapies and orphan products, and strengthen connections among patients, families, and clinicians to improve comprehensive care across the country effectively.
Methods
After ethics approval from the participating centres, data were collected in a structured format developed jointly by ICMR- National Institute of Immunohaematology, Mumbai and Postgraduate Institute of Medical Education and Research, Chandigarh, identified as nodal centres for inborn errors of immunity (IEI) by ICMR. Cases with molecular confirmation of diagnosis or those satisfying the European Society for Immunodeficiencies (ESID) registry working definition in absence of molecular confirmation were included. The Data were compiled in excel format and analysed using Epi Info v7.2.5.0.
Results
Data for 676 patients enrolled between January 2019- October 2024 from six participating centres including ICMR-NIIH Mumbai, PGI Chandigarh, Apollo Chennai, JIPMER Pondicherry, Nizams Institute Hyderabad, and Sir Gangaram Hospital Delhi was analysed. Immunodeficiencies affecting cellular and humoral immunity (CID) and CID with associated or syndromic features (n=187,27.6%), predominantly antibody deficiency (n=146,21.6%), congenital defects of phagocyte number or function (n=117,17.3%) were the most frequent IEIs. The median age of presentation was 16 (IQR 4,63) months and diagnostic delay of 16 (IQR 3,55) months. The presenting clinical manifestations comprised of recurrent infections (n=459,67.9%), autoimmunity or auto-inflammation (n=292,43.2%), adverse effect following immunisation (n=38,5.6%), and malignancy (n=5,0.73%). 103/146 (70%) patients with antibody deficiency received IVIG and 90 (13.3%) IEI patients underwent hematopoietic stem cell transplant. On follow up, 118 (17.4%) patients died due to infections by 2024. Interpretation and conclusions The IEI registry developed by ICMR as an attempt to maintain a patient database gives us insights on the demographic, clinical presentation, diagnostic-delay and treatment outcomes of these disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Immunology and Leucocyte Biology, ICMR- National Institute of Immunohaematology, Mumbai, Maharashtra, India.
- Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
- Department of Pediatrics, Apollo Hospital, Chennai, Tamil Nadu, India.
- Department of Medical Genetics, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India.
- Department of Pediatrics, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India.
- Institute of Medical Genetics & Genomics, Sir Gangaram Hospital, New Delhi, India.
Zitieren
APA
Yadav, R. M., Suri, D., Singh, S., Pandiarajan, V., Satheesh, C., Ranganath, P., Gulati, R., Puri, R. D., Temkar, L., Khalkho, P., Almas, Rajasekhar, L., Raj, R., Shukla, A., Rawat, A., Madkaikar, M., & NRROID Registry PID Contributors group (2026). Experiences from inborn errors of immunity registry of India: A preliminary report. The Indian Journal of Medical Research, 163, 207-214. https://doi.org/10.25259/ijmr_1850_2025
Vancouver
Yadav RM, Suri D, Singh S, Pandiarajan V, Satheesh C, Ranganath P, et al. Experiences from inborn errors of immunity registry of India: A preliminary report. The Indian Journal of Medical Research. 2026;163:207-214. doi:10.25259/ijmr_1850_2025
BibTeX
@article{Yadav2026,
author = {Yadav, Reetika Malik and Suri, Deepti and Singh, Surjit and Pandiarajan, Vignesh and Satheesh, C and Ranganath, Prajnya and Gulati, Reena and Puri, Ratna Dua and Temkar, Lavina and Khalkho, Persis and Almas and Rajasekhar, Liza and Raj, Revathy and Shukla, Amlin and Rawat, Amit and Madkaikar, Manisha and NRROID Registry PID Contributors group, NRROID Registry PID Contributors group},
title = {Experiences from inborn errors of immunity registry of India: A preliminary report},
journal = {The Indian Journal of Medical Research},
year = {2026},
volume = {163},
pages = {207--214},
doi = {10.25259/ijmr_1850_2025}
}
EUVIMED